Positive Phase 3 Clinical Study Results for Inavir(R) Dry Powder Inhaler, an Influenza Antiviral, for the Prevention of Influenza

Positive Phase 3 Clinical Study Results for Inavir(R) Dry Powder Inhaler, an Influenza Antiviral, for the Prevention of Influenza

TOKYO, Japan (August 22, 2012) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that the influenza antiviral  Read more